Peer-influenced content. Sources you trust. No registration required. This is HCN.

MedPage TodayCompetitor Poised to Take on Obesity Treatment Giant Wegovy in 2023

Fast-tracked tirzepatide is looking to join the diabetes-turned-obesity drug market. Additional options in the class could be a boon to patients, given the persisting semiglutide shortage.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form